Evaluation of Cross-Linked Polyelectrolyte (CLP) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2008

Conditions
Basic Science: Safety, Tolerability, Efficacy of CLP
Interventions
DRUG

Cross-Linked Polyelectrolyte (CLP)

CLP was administered orally, in capsules, for 9 consecutive days.

Trial Locations (1)

Unknown

Jasper Clinic, Inc., Kalamazoo

Sponsors
All Listed Sponsors
lead

Sorbent Therapeutics

INDUSTRY